U.S., Japan Regulators Begin Collaborative Review Pilot With Femoral Stents
This article was originally published in The Gray Sheet
Executive Summary
FDA and Japanese regulators recently began to work together to review two devices - one U.S.-manufactured, one Japanese-made - that are part of a new pilot program intended to model how products can achieve faster market entry in both countries